Media: Lack of buyers' interest in Novo Holdings-owned Xellia Pharmaceuticals

Equity firms haven’t shown any noteworthy interest in buying Danish Xellia Pharmaceuticals, which is owned by Novo Holdings.
Photo: Xellia Pharmaceuticals / PR
Photo: Xellia Pharmaceuticals / PR
by MIKKEL AABENHUS HEMMINGSEN, translated by daniel pedersen

Novo Holdings’ hopes of selling antibiotics producer Xellia Pharmaceuticals have run aground, Danish business daily Børsen has learned.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading